XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 29, 2025
Mar. 30, 2024
OPERATING ACTIVITIES    
Net income $ 29,806 $ 47,096
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 12,226 14,142
Non-cash interest charges 66 66
Provisions for losses on trade and other accounts receivable 6,455 3,854
Gains on sales/disposals of operating property (830) (248)
Deferred income taxes, net 146 (1,259)
Stock-based compensation 2,038 1,724
Changes in operating assets and liabilities:    
(Increase) decrease in trade and other accounts receivable (27,068) 18,871
Decrease in other assets 8,657 11,574
Increase (decrease) in accounts payable 5,967 (11,713)
Increase in other liabilities 8,514 10,497
Increase (decrease) in insurance claims 9,721 (396)
NET CASH PROVIDED BY OPERATING ACTIVITIES 55,698 94,208
INVESTING ACTIVITIES    
Sales and maturities of investments 46,858 19,923
Purchases of investments (48,085) (15,869)
Purchases of operating property (1,902) (9,281)
Proceeds from sales of operating property 4,276 1,585
NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES 1,147 (3,642)
FINANCING ACTIVITIES    
Decrease in cash overdraft (1,674) (9,867)
Dividends paid (83,320) (83,235)
Taxes paid in lieu of shares issued related to stock-based compensation plans (909) (3,060)
Purchases of common stock (60,361) 0
Principal payments on finance lease obligations (8,339) (7,239)
NET CASH USED BY FINANCING ACTIVITIES (154,603) (103,401)
Effect of exchange rate changes on cash and cash equivalents 160 (537)
Decrease in cash and cash equivalents (97,598) (13,372)
Cash and cash equivalents at beginning of period 515,018 481,043
Cash and cash equivalents at end of period $ 417,420 $ 467,671